Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
722
-
Total 13F shares, excl. options
-
91.9M
-
Shares change
-
-370K
-
Total reported value, excl. options
-
$37.8B
-
Value change
-
-$150M
-
Put/Call ratio
-
0.94
-
Number of buys
-
359
-
Number of sells
-
-338
-
Price
-
$412.23
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q3 2020
840 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q3 2020.
DEXCOM INC - Common Stock (DXCM) has 722 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91.9M shares
of 392M outstanding shares and own 23.42% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (10.4M shares), FMR LLC (8.57M shares), BlackRock Inc. (7.26M shares), BAILLIE GIFFORD & CO (4.23M shares), MORGAN STANLEY (4.12M shares), STATE STREET CORP (3.93M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.1M shares), JPMORGAN CHASE & CO (3.07M shares), JENNISON ASSOCIATES LLC (2.74M shares), and SANDS CAPITAL MANAGEMENT, LLC (2.33M shares).
This table shows the top 722 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.